Ibuprofen Max Laboratoria Polfałódź (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish pain signalling, lower the hypothalamic set‑point for body temperature, and limit the inflammatory response.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety in pregnancy and lactation depends on the trimester and individual risk factors. Ibuprofen is generally avoided in the third trimester and should only be used during pregnancy or while breastfeeding if the prescriber deems the benefits to outweigh potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ibuprofen shares a similar mechanism with other NSAIDs such as naproxen and diclofenac, offering comparable analgesic and anti‑inflammatory effects. Compared with acetaminophen, ibuprofen additionally provides anti‑inflammatory activity but carries a higher risk of gastrointestinal irritation and renal effects, especially at higher doses.

Ibuprofen Max Laboratoria Polfałódź should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The product is intended for oral administration. Tablets are swallowed whole with a full glass of water, preferably with food or milk to reduce gastrointestinal discomfort, unless otherwise directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, renal impairment, hepatotoxicity, and an increased risk of cardiovascular events, particularly with high‑dose or prolonged therapy.

Ibuprofen is contraindicated in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe renal or hepatic impairment, and in the third trimester of pregnancy. It should also be used with caution in patients with uncontrolled hypertension or heart failure.